rs2293564

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004304.5(ALK):​c.1500A>G​(p.Gln500Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.894 in 1,613,924 control chromosomes in the GnomAD database, including 651,853 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.80 ( 51141 hom., cov: 32)
Exomes 𝑓: 0.90 ( 600712 hom. )

Consequence

ALK
NM_004304.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.140

Publications

29 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-29320797-T-C is Benign according to our data. Variant chr2-29320797-T-C is described in ClinVar as Benign. ClinVar VariationId is 259266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.1500A>Gp.Gln500Gln
synonymous
Exon 7 of 29NP_004295.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.1500A>Gp.Gln500Gln
synonymous
Exon 7 of 29ENSP00000373700.3Q9UM73
ALK
ENST00000618119.4
TSL:5
c.369A>Gp.Gln123Gln
synonymous
Exon 6 of 28ENSP00000482733.1A0A087WZL3
ENSG00000286963
ENST00000655343.1
n.220+824T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.801
AC:
121799
AN:
152014
Hom.:
51134
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.515
Gnomad AMI
AF:
0.958
Gnomad AMR
AF:
0.874
Gnomad ASJ
AF:
0.898
Gnomad EAS
AF:
0.914
Gnomad SAS
AF:
0.868
Gnomad FIN
AF:
0.917
Gnomad MID
AF:
0.864
Gnomad NFE
AF:
0.919
Gnomad OTH
AF:
0.829
GnomAD2 exomes
AF:
0.878
AC:
220708
AN:
251468
AF XY:
0.884
show subpopulations
Gnomad AFR exome
AF:
0.504
Gnomad AMR exome
AF:
0.885
Gnomad ASJ exome
AF:
0.896
Gnomad EAS exome
AF:
0.907
Gnomad FIN exome
AF:
0.914
Gnomad NFE exome
AF:
0.918
Gnomad OTH exome
AF:
0.896
GnomAD4 exome
AF:
0.904
AC:
1321580
AN:
1461792
Hom.:
600712
Cov.:
57
AF XY:
0.904
AC XY:
657332
AN XY:
727190
show subpopulations
African (AFR)
AF:
0.492
AC:
16485
AN:
33478
American (AMR)
AF:
0.885
AC:
39597
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.897
AC:
23442
AN:
26136
East Asian (EAS)
AF:
0.906
AC:
35962
AN:
39700
South Asian (SAS)
AF:
0.866
AC:
74717
AN:
86252
European-Finnish (FIN)
AF:
0.919
AC:
49068
AN:
53420
Middle Eastern (MID)
AF:
0.869
AC:
5000
AN:
5752
European-Non Finnish (NFE)
AF:
0.921
AC:
1023908
AN:
1111948
Other (OTH)
AF:
0.884
AC:
53401
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
7398
14796
22193
29591
36989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21464
42928
64392
85856
107320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.801
AC:
121840
AN:
152132
Hom.:
51141
Cov.:
32
AF XY:
0.803
AC XY:
59713
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.514
AC:
21313
AN:
41430
American (AMR)
AF:
0.874
AC:
13380
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.898
AC:
3118
AN:
3472
East Asian (EAS)
AF:
0.914
AC:
4717
AN:
5162
South Asian (SAS)
AF:
0.870
AC:
4198
AN:
4824
European-Finnish (FIN)
AF:
0.917
AC:
9720
AN:
10602
Middle Eastern (MID)
AF:
0.871
AC:
256
AN:
294
European-Non Finnish (NFE)
AF:
0.919
AC:
62522
AN:
68018
Other (OTH)
AF:
0.825
AC:
1744
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1042
2084
3126
4168
5210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.872
Hom.:
45477
Bravo
AF:
0.785
Asia WGS
AF:
0.842
AC:
2928
AN:
3478
EpiCase
AF:
0.917
EpiControl
AF:
0.913

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Neuroblastoma, susceptibility to, 3 (6)
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
8.0
DANN
Benign
0.39
PhyloP100
-0.14
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293564; hg19: chr2-29543663; COSMIC: COSV66566490; COSMIC: COSV66566490; API